Advertisement

Surgical Endoscopy

, Volume 24, Issue 3, pp 692–696 | Cite as

RETRACTED ARTICLE: Reduction of postoperative nausea, vomiting, and analgesic requirement with dexamethasone for patients undergoing laparoscopic cholecystectomy

  • Y. FujiiEmail author
  • M. Itakura
Article

Abstract

Background

Dexamethasone has antiemetic and analgesic effects for various types of surgery. The efficacy of dexamethasone for reducing postoperative nausea and vomiting (PONV) and analgesic requirement has never been evaluated for patients undergoing laparoscopic cholecystectomy (LC).

Methods

In a prospective, randomized, double-blind, placebo-controlled study, patients intravenously received placebo, dexamethasone 4 mg, or dexamethasone 8 mg immediately before induction of anesthesia. A standard anesthetic technique, including sevoflurane and air in oxygen, was used. Postoperatively, emetic symptoms (nausea, retching, and vomiting) and analgesic requirement were evaluated by an investigator.

Results

The study enrolled 90 patients (38 men and 52 nonpregnant women), with each treatment group comprising 30 patients. The rate of patients experiencing PONV 0–24 h after anesthesia was 60% for the dexamethasone 4 mg group (p = 0.294) and 33% for the dexamethasone 8 mg group (p = 0.01), compared with 70% for the placebo group. The need for indomethacin to relieve intolerable pain was less in the dexamethasone 8 mg group than in the placebo group (p = 0.008) or the dexamethasone 4 mg group (p = 0.029). No difference in analgesic requirement was found between the dexamethasone 4 mg group and the placebo group (p = 0.395). No clinically important adverse effects due to the study drug were observed in any group.

Conclusions

Prophylactic therapy with dexamethasone 8 mg is effective in reducing PONV and analgesic requirement for patients undergoing LC.

Keywords

Antiemetics Complications Dexamethasone Laparoscopic cholecystectomy Pain Vomiting 

References

  1. 1.
    Watcha MF, White PF (1992) Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 77:162–184PubMedCrossRefGoogle Scholar
  2. 2.
    Kovac AL (2000) Prevention and treatment of postoperative nausea and vomiting. Drugs 59:213–243PubMedCrossRefGoogle Scholar
  3. 3.
    Naguib M, Bakry AKE, Khoshim MHB, Channa AB, Gammal ME, Gammal KE, Elhattab YS, Attia M, Jaroudi R, Saddique A (1996) Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron, and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 43:226–231PubMedCrossRefGoogle Scholar
  4. 4.
    Wang JJ, Ho ST, Liu YH, Lee SC, Liu YC, Liao YC, Ho CM (1999) Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 83:772–775PubMedCrossRefGoogle Scholar
  5. 5.
    Wang JJ, Ho ST, Uen YH, Lin MT, Chen KT, Huang JC, Tzeng JI (2002) Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline. Anesth Analg 95:229–232PubMedCrossRefGoogle Scholar
  6. 6.
    Japan Pharmaceutical Information Center (2007) Drugs in Japan: ethical drugs. Jiho Inc., TokyoGoogle Scholar
  7. 7.
    Aapro MS, Alberts DS (1981) Dexamethasone as an antiemetic in patients treated with cisplatin. N Engl J Med 305:520PubMedGoogle Scholar
  8. 8.
    Holte K, Kehlet H (2002) Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 195:694–712PubMedCrossRefGoogle Scholar
  9. 9.
    Henzi I, Walder B, Tramer MR (2000) Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 90:186–194PubMedCrossRefGoogle Scholar
  10. 10.
    Feo CV, Sortini D, Ragazi R, Palma M, Liboni A (2006) Randomized clinical trial of the effect of preoperative dexamethasone on nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 93:295–299PubMedCrossRefGoogle Scholar
  11. 11.
    Iitomi T, Toriumi S, Kondo A, Akazawa T, Nakahara T (1995) Incidence of nausea and vomiting after cholecystectomy performed via laparotomy or laparoscopy (Japanese). Masui 44:1227–1231PubMedGoogle Scholar
  12. 12.
    Ramsay TM, McDonald PF, Faragher EB (1994) The menstrual cycle and nausea and vomiting after wisdom teeth extraction. Can J Anaesth 41:798–801PubMedCrossRefGoogle Scholar
  13. 13.
    Liu K, Hsu CC, Chia YY (1999) The effective dose of dexamethasone for antiemetics after major gynecological surgery. Anesth Analg 83:772–775Google Scholar
  14. 14.
    Wattwil M, Thorn SE, Lovqvist A, Wattwil L, Gupta A, Liljegren G (2003) Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand 47:823–827PubMedCrossRefGoogle Scholar
  15. 15.
    Splinter WM, Roberts DJ (2000) Dexamethasone decreases vomiting by children after tonsillectomy. Anesth Analg 90:186–194CrossRefGoogle Scholar
  16. 16.
    Fredrikson M, Hursti T, Furst CJ, Steineck G, Borjeson S, Wikblom M, Peterson C (1992) Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer 65:779–780PubMedCrossRefGoogle Scholar
  17. 17.
    Aapro MS, Plezia PM, Alberts DS, Graham V, Jones SE, Surwit EA, Moon TE (1984) Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol 2:466–471PubMedGoogle Scholar
  18. 18.
    Livrea P, Trojano M, Simone IL, Zimatore GB, Logroscino GC, Pisicchio L, Lojacono G, Collella R, Ceci A (1985) Acute changes in blood–CFS barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation. J Neurol 231:336–339PubMedCrossRefGoogle Scholar
  19. 19.
    Baxendale BR, Vater M, Lavery KM (1993) Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia 48:961–964PubMedCrossRefGoogle Scholar
  20. 20.
    Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55–89PubMedCrossRefGoogle Scholar
  21. 21.
    Schimmer BP, Parker KL (2001) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon PW, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 1649–1677Google Scholar
  22. 22.
    McCormick C (2002) FDA alert: current FDA report on droperidol status and basis for “black box” warning. Am Soc Anesthesiol Newslett 66:19–20Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of AnesthesiologyUshiku Aiwa General HospitalIbarakiJapan
  2. 2.First Department of AnesthesiologyToho University School of MedicineTokyoJapan

Personalised recommendations